IRIS
ROSELLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 61.468
AS - Asia 7.626
EU - Europa 6.081
SA - Sud America 1.124
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 15
Totale 76.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 61.210
SG - Singapore 3.696
CN - Cina 1.443
IT - Italia 1.101
BR - Brasile 929
DE - Germania 884
RU - Federazione Russa 853
UA - Ucraina 770
HK - Hong Kong 638
VN - Vietnam 637
IE - Irlanda 636
FR - Francia 450
GB - Regno Unito 339
FI - Finlandia 279
KR - Corea 271
PL - Polonia 251
JP - Giappone 210
BD - Bangladesh 207
SE - Svezia 188
IN - India 142
CA - Canada 139
NL - Olanda 113
ID - Indonesia 92
AR - Argentina 74
MX - Messico 61
IQ - Iraq 49
AT - Austria 43
ES - Italia 42
EC - Ecuador 35
ZA - Sudafrica 34
BE - Belgio 30
TR - Turchia 30
PK - Pakistan 25
CO - Colombia 24
SA - Arabia Saudita 21
CZ - Repubblica Ceca 20
EU - Europa 19
MA - Marocco 18
PH - Filippine 18
CL - Cile 17
MY - Malesia 17
JM - Giamaica 15
LT - Lituania 15
PY - Paraguay 15
TW - Taiwan 15
AU - Australia 14
EG - Egitto 14
AE - Emirati Arabi Uniti 13
UZ - Uzbekistan 13
VE - Venezuela 13
CR - Costa Rica 11
GR - Grecia 11
RO - Romania 11
CH - Svizzera 10
HN - Honduras 10
KE - Kenya 9
TH - Thailandia 9
IR - Iran 8
NP - Nepal 8
AL - Albania 7
AZ - Azerbaigian 7
KG - Kirghizistan 7
PE - Perù 7
UY - Uruguay 7
JO - Giordania 6
KZ - Kazakistan 6
PT - Portogallo 6
DZ - Algeria 5
IL - Israele 5
NI - Nicaragua 5
OM - Oman 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
NO - Norvegia 4
QA - Qatar 4
BG - Bulgaria 3
GT - Guatemala 3
LB - Libano 3
MN - Mongolia 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
AO - Angola 2
BH - Bahrain 2
BZ - Belize 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
LK - Sri Lanka 2
NG - Nigeria 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
Totale 76.417
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.858
Wilmington 15.438
Houston 14.799
Singapore 1.802
Fairfield 1.669
Ashburn 1.188
Ann Arbor 1.013
San Jose 981
Chandler 831
Seattle 696
Jacksonville 682
Cambridge 632
Hong Kong 622
Dublin 569
Beijing 522
Medford 432
Council Bluffs 359
Rome 356
Santa Clara 341
New York 311
Dearborn 287
The Dalles 284
Kraków 215
Los Angeles 203
Ho Chi Minh City 201
Lawrence 199
Tokyo 173
Dallas 164
Hanoi 161
Buffalo 160
Lauterbourg 146
Moscow 143
San Diego 139
Menlo Park 122
Helsinki 100
Zhengzhou 96
Orem 87
Milan 86
Chicago 84
São Paulo 83
Engelhard 73
London 61
Jakarta 60
Mülheim 56
Nuremberg 53
Saint Petersburg 49
Boardman 48
Redondo Beach 47
Falls Church 46
Chennai 44
Phoenix 43
Nanjing 40
Montreal 39
Shanghai 38
Norwalk 37
Guangzhou 35
Hefei 35
Munich 35
Redwood City 34
Salt Lake City 33
North Bergen 31
Warsaw 31
Brooklyn 30
Brussels 30
Detroit 29
Frankfurt am Main 29
Rio de Janeiro 28
Toronto 28
Amsterdam 27
Porto Alegre 27
Columbus 26
Denver 26
Manchester 26
Mountain View 26
Boston 24
Da Nang 24
Lappeenranta 24
Kunming 23
University Park 23
Tampa 22
Hangzhou 21
Verona 21
Atlanta 20
Curitiba 20
Palo Alto 20
Belo Horizonte 19
Mexico City 19
Miami 19
Mumbai 19
Seoul 19
Turin 19
Johannesburg 18
Dong Ket 16
Elk Grove Village 16
Haiphong 16
Naples 16
Nürnberg 16
Poplar 16
Stockholm 16
Vienna 16
Totale 65.036
Salva come PNG Salva come JPEG
Nome #
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 671
Soluble selectin levels in patients with lung cancer 622
Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma 554
Role of serum and glucocorticoid-inducible kinase (SGK)-1 in senescence: a novel molecular target against age-related diseases 552
Sex-Genetic Interaction in the Risk for Cerebrovascular Disease 533
Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors 528
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 521
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 496
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 494
Pathological classification of DCIS and planning of therapeutic management 493
Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies 489
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study 481
Aging: an important risk factor in chemotherapy-associated vascular diseases 480
Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice 477
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 477
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 476
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 475
Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer 472
Minimal sentinel node procedure for staging early breast cancer 470
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass 470
Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia 468
Adjuvant chemotherapy for stage IB non-small cell lung cancer 467
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer 467
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 466
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 463
Effects of conventional therapeutic interventions on the number and function of regulatory T cells 463
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 461
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 461
Biological and predictive role of ERCC1 polymorphisms in cancer 461
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 460
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy 460
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 460
Clinical models and biochemical predictors of VTE in lung cancer 459
Day-surgical management of ductal carcinoma in situ (DCIS)of the breast using wide local excision with sentinel node biopsy 457
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 455
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy 454
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 454
Immune reaction and colorectal cancer: friends or foes? 453
Prognostic value of glycated hemoglobin in colorectal cancer 453
Sentinel lymphadenectomy in cutaneous melanoma 452
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer 452
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 452
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 452
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 451
Cardiac surgery with extracorporeal circulation in cancer patients: risk factors for late survival and cancer-related event-free survival 450
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 449
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 449
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 449
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) 448
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients 447
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer 446
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 446
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 442
Thromboembolic events in patients treated with anti-angiogenic drugs 441
Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients 438
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 438
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients 436
Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' 435
Chemoprevention of colonic cancer: is there a foreseeable future? 434
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer 434
Monoclonal antibodies in gastrointestinal cancers 432
The value of soluble selectin levels in the management of lung cancer patients 431
Prognostic value of soluble P-selectin levels in colorectal cancer 429
Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience 429
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 428
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 428
Determinants of homocysteine levels in colorectal and breast cancer patients 427
Family history of cancer in patients with gastric cancer 426
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer 422
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice 422
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: Pros and cons 422
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 421
Percutaneous cryoablation and vertebroplasty: a case report 420
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis 420
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience 419
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients 419
VEGF and VTE risk in cancer patients-letter 419
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study 417
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 417
Insulinemia and the risk of breast cancer and its relapse 416
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer 416
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study 415
Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer 415
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 414
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 414
[Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node] 414
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 413
CD26: a multi-purpose pharmacological target 412
Radiofrequency Heat Ablation and Vertebroplasty in the treatment of neoplastic vertebral body fractures 411
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial 410
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 410
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy 408
Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis 407
Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer 406
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet 405
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 405
Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes 405
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 405
In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts 405
The use of B72.3 second generation (CC) monoclonal antibody for the radioimmunolocalization of human carcinoma xenografts 404
Totale 44.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.053
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.273 108 237 84 103 98 178 199 178 139 256 165 528
2022/20232.392 261 198 55 264 232 588 204 150 183 28 162 67
2023/20241.035 106 34 59 40 93 237 154 47 22 32 7 204
2024/20255.794 164 1.229 550 300 120 333 405 272 548 566 783 524
2025/20269.274 674 470 1.113 683 815 320 1.024 1.156 1.049 781 787 402
2026/202749 49 0 0 0 0 0 0 0 0 0 0 0
Totale 77.143